Aius-To evaluate the Questor automated bacteriuria and pyuria screening system; to compare its performance with that of a reference method; and to assess its usefulness in a routine clinical laboratory.
Methods-The Questor urine screening system was compared with a comprehensive regimen to detect urinary tract infection, using pour-plate viable counts to determine the numbers of bacteria present in urine samples, a wide range of other cultural methods, microscopic findings and clinical information. Results-The optimal performance in detecting significant growths was a sensitivity of 93%, a specificity of 74%, a positive predictive value of 43% and a negative predictive value of 98%. The list price per test is £0.17 and the capital cost of the system is £39 950. Questor can test 50 samples an hour and can be operated by one member of the laboratory staff, who is not required to make interpretative judgments-for example, a medical laboratory assistant. Conclusions-The sensitivity and specificity of the Questor was better than that obtained from other screening systems using the same protocol. The system was easy to use and is a useful addition to the methods available for screening for bacteriuria. Urinary infections are second only in prevalence to those of the upper respiratory tract. But the number of requests submitted to clinical microbiology laboratories for the microbiological examination of urine far exceeds the number of upper respiratory tract specimens. Bacteriuria may be chronic, persistent, and possibly influence structure and function outside the urinary tract. It has an important role in disease throughout life, from prematurity to hypertension and renal failure.' Many methods for screening for bacteriuria have been described and reviewed,2 but there remains a need for an accurate, rapid, cost effective system for use in routine clinical laboratories. Questor (Difco Laboratories Ltd, East Molesey, Surrey) is an automated system which is designed to categorise and enumerate bacteria and other cells found in urine using particle counting technology.
An evaluation of the system was commissioned by the Medical Devices Directorate of the Department of Health and carried out at the Leicester Public Health Laboratory.
The system's performance was compared with a comprehensive reference method which included a variety of cultural techniques, microscopic examination, and clinical information. A full report of the evaluation has been produced.' Methods The Questor system (fig 1) is an automated single-channel impedance particle counter which uses a direct physical method to count and categorise particles. A 100 PI aliquot of the urine to be tested is pipetted into one well of an eight-well disposable plastic tray which is then placed in the instrument. The following automatic process is then carried out. The specimen is diluted with a conductive electrolyte solution and offered to a particle counting probe (fig 2) . There is a small orifice (A) in the glass end of the probe which also contains two platinum electrodes, one internal (B) and one external (C). An electrical field is established between the electrodes via the electrolyte in the orifice. The sample is drawn through the orifice under vacuum. As a particle is drawn through the orifice and enters the electrical field, it displaces its own volume of electrolyte, causing a change in the impedance of the electrical circuit. The changes are detected as pulses, the number of which indicate the quantity of particles present in the sample.
The height and area of the pulse is propor- is above the selected threshold-.50/pl-the interpretation given is "pos-white cell". If the erythrocyte count is above the selected threshold-,250/pl-the interpretation given is "pos-red blood cell". The user has the option of choosing a threshold value for any combination of organisms, leucocytes, and erythrocytes above which results are interpreted as positive.
A previous evaluation of the Ramus urine screening system,4 which utilised particle counting, showed that the fixed, small size orifice used was prone to blocking. In the Questor system the manufacturers claim that, "putting the insert into the orifice forms an annulus. The flow pattern sets up a standing wave at the entrance of the annulus. This wave sweeps the large particles away from the annulus but allows the small particles through. This is called the 'filter effect', which greatly reduces the incidence of probe blockage."
Apart from the Questor system, the items required for testing urines are plastic trays and particle-free isotonic diluent (both of which are supplied by the manufacturer), a micropipette and tips, plastic waste disposal bags, and computer consumables: paper, ribbons and floppy disks. 
Evaluation methods

Statistical analyses
The results of individual tests from Questor and the reference method were categorised (table 2) . From the many possible combinations of thresholds, the optimal performance was calculated using the method of Koenig et al. 7 In this method sensitivity is weighted more heavily than specificity, because the consequences of reporting a false negative result are potentially more serious than those of a the false positive results, organisms were present in numbers greater than 105 cfu/ml. Antibiotic substances were detected in a significantly higher percentage (47 of 220, or 21%) of the false positive samples compared with 147/1023 (14%) of all the samples tested (p = 0-001).
Questor assigned the following interpretation to the true positive results: (n = number of samples in category): "positive" 105, "poswhite cells" 48, and "pos-red blood cells" 10. Comparisons between the Questor leucocyte, erythrocyte, and epithelial cells counts and microscopy are given in tables 5, 6, and 7 respectively.
Discussion
The Questor system was more sensitive and specific than other bacteriuria screening systems evaluated using the same protocol. 489 The results showed that the system was able selectively to detect bacteria, leucocytes, erythrocytes and epithelial cells. The bacterial counts given were accurate, except below 1.0 x 104 and above 1 1 x 105, and the evaluators suggest that as part of the installation process for individual laboratories, the software should be configured so that results outside these figures should read <1 0 x 104 and >1 0 x 105, respectively.
Although Questor recorded a false positive result for 220 specimens, many of these could be accounted for by the presence of anaerobic or carboxyphilic organisms, or the presence of antimicrobial substances and therefore the possibility of the presence of non-viable bacteria.
A total of 109 of the 220 false positive results contained high numbers of leucocytes and although no organisms were detected in these samples, these high leucocyte counts have diagnostic value. Questor has a tendency to give higher leucocyte and erythrocyte counts than is found by microscopy (tables 5 and 6).
Individual laboratories using Questor have the option of choosing any combination of different positive threshold levels for organisms, leucocytes, and erythrocytes. Changing these thresholds will alter the performance, increasing the sensitivity and lowering the specificity or vice versa. This may be important when testing urine samples from particular groups of patients. In a patient population with a low incidence of urinary tract infection the thresholds could be changed to increase the specificity; in a symptomatic group, a high sensitivity is required. It is recommended that each user laboratory should calibrate the system by comparing the results obtained with those of the best possible comparative method.
Because the operator involvement in the analytical process consists only of pipetting 100 41l of urine sample into a tray and entering the sample number into the computer system, with no interpretive steps, a medical laboratory assistant can be used to operate the system. In this evaluation it was possible for a medical laboratory assistant to operate the Questor system and to process 230 urine samples a day. As Questor takes about 1 minute to process one sample, in theory it would be possible for the system to test over 400 samples in a normal working day. This, however, would rely on specimens being received at regular intervals and therefore available for testing as a continuous workload throughout the day. In practice this did not occur, with most samples being received in mid-afternoon. Questor is a system designed to screen urines, allowing a negative result to be sent from the laboratory in most cases on the same day as specimen receipt.
This could have some beneficial impact on patient care, although this would depend greatly on both the speed at which the specimen is sent to the laboratory after voiding and how quickly the report is sent to the requesting physician. A benefit to the laboratory would be that the negative specimens would not be cultured and therefore not require the preparation and interpretation of culture plates by laboratory staff. Specimens recorded as positive by Questor would require culture, to identify causative organisms, to provide cultures for antimicrobial susceptibility tests, and to detect mixed, possibly insignificant growths.
The list price capital cost of the Questor system is £39 950. The list price costs of the consumables required, diluent, and trays total ,C0-17 a sample. The WELCAN workload system, when applied to all procedures associated with urine screening by Questor and a routine microscopical and cultural method, showed a saving of staff time of 31% when using the automated method.
The system was simple to use, was liked by laboratory staff, and had excellent, userfriendly software. The ability of the system to provide an accurate rapid, result, the savings in staff time taken to process samples make the Questor system an important and useful addition to the methods available for screening for bacteriuria.
